Get Your Personalized Supplement StackSupplement Stack Quiz

Burn Blend

Also known as: Glutamine, L-glutamine, GLN

Overview

Glutamine is a conditionally essential amino acid, meaning the body can typically produce it, but during periods of severe physiological stress, such as extensive burn injuries, its demand exceeds production, making supplementation necessary. It is naturally found in protein-rich foods like meat, fish, eggs, and dairy. In the context of "Burn Blend" supplements, glutamine is a key active ingredient studied for its role in supporting recovery in burn patients. It serves as a vital fuel source for rapidly dividing cells, including immune cells and enterocytes (cells lining the gut), and plays a crucial role in nitrogen transport and maintaining acid-base balance. Research, including multiple randomized controlled trials and meta-analyses, has extensively evaluated its efficacy in severely burned patients, demonstrating its ability to support immune function, reduce infection risk, and improve overall clinical outcomes. The evidence quality for glutamine's benefits in this population is considered high.

Benefits

Glutamine supplementation offers significant, evidence-based benefits for severely burned patients, particularly those with critical illness and large total burn surface area. High-quality evidence from systematic reviews and meta-analyses of randomized controlled trials consistently demonstrates several key advantages. Firstly, it significantly reduces mortality risk, with meta-analyses showing a relative risk reduction of approximately 91% (RR = 0.09, 95% CI 0.01 to 0.63, p=0.016). Secondly, glutamine substantially lowers the risk of infection-related morbidity, with a relative risk reduction of about 59% (RR = 0.41, 95% CI 0.18 to 0.92, p=0.030). Thirdly, it has been shown to shorten the hospital length of stay by an average of approximately 9 days (MD = -8.97, 95% CI -15.22 to -2.71, p=0.005). While there's a trend towards reduced wound infection incidence, it's not always statistically significant. These benefits are clinically meaningful and are typically observed during the acute hospitalization phase, within weeks post-burn injury.

How it works

Glutamine exerts its therapeutic effects primarily by supporting immune cell proliferation, enhancing gut barrier function, and serving as a precursor for nucleotide synthesis. It acts as a critical fuel source for rapidly dividing cells, including lymphocytes and macrophages, thereby modulating the immune response and improving the body's ability to fight infection. By strengthening the gut barrier, glutamine helps prevent bacterial translocation from the intestines into the bloodstream, a common complication in severe burns. It also supports tissue repair and regeneration. Glutamine is well absorbed, particularly when administered enterally, and its bioavailability is generally sufficient to achieve therapeutic concentrations, even in critically ill patients.

Side effects

Glutamine is generally considered safe for severely burned patients at the studied doses, with no major adverse effects consistently reported in clinical trials. Common side effects (occurring in more than 5% of patients) have not been identified. Similarly, uncommon (1-5%) and rare (less than 1%) side effects are not well documented or have not been reported as significant adverse events. There are no major drug interactions identified with glutamine supplementation. While specific contraindications are not established, caution may be warranted in patients with severe renal or hepatic impairment, although this is not a common concern in the acute burn setting. The safety profile is primarily established in critically ill burn patients, and its safety in other populations is less extensively studied. Overall, the risk-benefit profile strongly favors glutamine use in this specific patient group.

Dosage

The optimal dosage of glutamine for severely burned patients typically ranges from 0.3 to 0.5 grams per kilogram of body weight per day (g/kg/day). This range is based on findings from numerous clinical trials. Doses above 0.75 g/kg/day have been rarely studied, so their safety and efficacy are less established. Early initiation of supplementation post-burn injury is strongly recommended to maximize benefits, ideally as soon as enteral feeding is tolerated. Glutamine can be administered enterally (preferred route, if gut function allows) or parenterally. For enteral administration, adequate gut function is necessary for proper absorption. No specific cofactors are required for glutamine's efficacy, but it should be part of a comprehensive nutritional support regimen for burn patients.

FAQs

Is glutamine supplementation safe for burn patients?

Yes, glutamine is generally considered safe for severely burned patients. Clinical trials have not reported major adverse effects at recommended doses, while demonstrating significant benefits in reducing mortality and infection risk.

When should glutamine supplementation start?

Early initiation of glutamine supplementation is advised. It should ideally begin as soon as possible after the burn injury, once enteral feeding is tolerated, to maximize its therapeutic effects during the acute phase.

How soon can benefits be expected from glutamine?

Benefits such as reduced infection rates and improved survival are typically observed during the acute hospitalization period, often within weeks of initiating glutamine supplementation in severely burned patients.

Is glutamine effective alone or as part of a blend?

Most high-quality evidence supporting glutamine's benefits in burn patients is for glutamine administered as a single agent. While it may be included in 'Burn Blend' formulations, the efficacy of other components in such blends requires separate evaluation.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/36578449/ – This systematic review and meta-analysis of 7 RCTs involving 328 burn patients found that glutamine significantly reduced mortality (RR=0.09, p=0.016) and infection risk (RR=0.41, p=0.030). The study highlights glutamine's high efficacy in improving outcomes for burn patients despite some heterogeneity in study designs.
https://pubmed.ncbi.nlm.nih.gov/38243579/ – This systematic review and meta-analysis, published in J Burn Care Res, confirmed the benefits of glutamine in burn patients, specifically noting reductions in mortality and length of stay. It supports glutamine's established therapeutic role in acute burn care, acknowledging variability across study designs.
https://mednexus.org/doi/abs/10.1016/j.cjtee.2023.06.005 – This systematic review and meta-analysis from the Chinese Journal of Trauma and Emergency demonstrated a significant reduction in hospital length of stay (MD = -8.97 days, p=0.005) with glutamine supplementation in burn patients. It also noted a trend towards reduced wound infection, reinforcing glutamine's clinical utility.